SORD Antikörper (Middle Region)
Kurzübersicht für SORD Antikörper (Middle Region) (ABIN954884)
Target
Alle SORD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 210-239, Middle Region
-
Spezifität
- This antibody recognizes Human SORD (Center).
-
Aufreinigung
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 210-239 amino acids from the Central region of Human SORD. Genename: SORD
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SORD (Sorbitol Dehydrogenase (SORD))
-
Andere Bezeichnung
- SORD
-
Hintergrund
- Sorbitol dehydrogenase (SORD, EC 1.1.1.14) catalyzes the interconversion of polyols and their corresponding ketoses, and together with aldose reductase (ALDR1, MIM 103880), makes up the sorbitol pathway that is believed to play an important role in the development of diabetic complications (summarized by Carr and Markham, 1995 [PubMed 8535074]). The first reaction of the pathway (also called the polyol pathway) is the reduction of glucose to sorbitol by ALDR1 with NADPH as the cofactor. SORD then oxidizes the sorbitol to fructose using NAD(+) cofactor. Synonyms: L-iditol 2-dehydrogenase, Sorbitol dehydrogenase
-
Molekulargewicht
- 38325 Da
-
Gen-ID
- 6652
-
NCBI Accession
- NP_003095
Target
-